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ABSTRACT  
Ferrocenyl phosphine thioether ligands (PS), not containing deprotonatable functions, efficiently 
support the iridium catalyzed ketone hydrogenation in combination with a strong base co-catalyst. 
Use of an internal base ([Ir(OMe)(COD)]2 in place of [IrCl(COD)]2) is not sufficient to insure 
activity and a strong base is still necessary, suggesting that the active catalyst is an anionic hydride 
complex. Computational investigations that include solvent effects demonstrate the 
thermodynamically accessible generation of the tetrahydrido complex [IrH4(PS)]
- and suggest an 
operating cycle via a [Na+(MeOH)3∙∙∙Ir-H4(PS)] contact ion pair with an energy span of 18.2 
kcal/mol. The cycle involves an outer sphere stepwise H-/H+ transfer, the proton originating from 
H2 after coordination and heterolytic activation. The base plays the dual role of generating the 
anionic complex and providing the Lewis acid co-catalyst for ketone activation. The best cycle for 
the neutral system, on the other hand, requires an energy span of 26.3 kcal/mol. This work 
highlights, for the first time, the possibility of outer sphere hydrogenation in the presence of non 
deprotonatable ligands and the role of the strong base in the activation of catalytic systems with 
such type of ligands.  
  
 3 
Introduction 
 
The reduction of carbonyl compounds and particularly the enantioselective reduction of 
prochiral ketones, leading to optically pure secondary alcohols, has been the topic of a considerable 
number of studies because of its significance for the manufacture of pharmaceuticals and advanced 
materials.1-4  Remarkable efforts have been devoted to the development of this method by using 
organometallic complexes as catalysts. The majority of the work carried out in this area has 
employed ruthenium-based pre-catalysts in combination with a variety of phosphine and amine 
ligands.5-10 Of these, the family of [RuCl2(diphosphine)(diamine)] molecules developed by 
Noyori, Ikariya, Ohkuma and coworkers stands out.11-14 Efficient enantioselective catalysts based 
on rhodium,15-17 iridium,18-26 and iron27-36 have also been reported in the literature.  Interest in 
iridium as a catalytic metal is sparked by the observation that it outperforms rhodium for the ionic 
hydrogenation of particularly difficult substrates such as imines and industrial processes based on 
Ir-catalyzed ketone hydrogenation have been implemented.37-40  
Contrary to olefins, unsaturated oxygenated substrates may be hydrogenated by the outer sphere 
mechanism,41, 42 without substrate coordination. These processes are also characterized by the need 
of a strong base co-catalyst in order to function. In the generally accepted view, a proton from a 
metal coordinated XH function (typically an amine) is transferred to the O atom and a hydride is 
transferred to the C atom (Scheme 1, I  II).43 The invoked role of the base in Noyori’s systems 
is to allow the catalyst to remain in a more active neutral form (cycle B), whereas only the slower 
cycle A via the protonated form III would occur without base.44 Indeed, certain isolated amido 
systems (e.g. complexes of type II) are active catalysts in the absence of added base.43 
Computational explorations of this mechanism, mostly carried out in the gas phase, have analyzed 
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the neutral cycle (B) but have not addressed the role of the base,43, 45-66 except for occasionally 
verifying that the base-promoted HCl removal from a chloride complex pre-catalyst is 
exothermic.67 Only one recent study has addressed the role of the base, using a solvent model, for 
the further deprotonation of the NH donor function in the neutral hydride complex with generation 
of a more active anionic complex.68 
 
 
Scheme 1. “Classical” outer sphere mechanism for the hydrogenation of ketones. 
 
There are, however, efficient systems that do not contain active protons and yet a strong base is 
crucial. For instance, the iridium complexes [Ir(COD)(1R)Cl] (2R where 1R = {CpFe[1,2-
C5H3(PPh2)(CH2SR)}, Scheme 2)
69 are good pre-catalysts for aromatic ketone hydrogenation in 
alcohol solvents,70 although only in the presence of a strong base such as MeONa or tBuOK. No 
significant activity was observed in the absence of H2 or when a weaker base such as NEt3 was 
used.  This behavior is shared by many other catalysts that are devoid of active protons, whether 
they are used in hydrogenation20 or transfer hydrogenation.71-80 The common view is that the base 
is needed to eliminate the acidity generated during the catalyst activation step. Contrary to other 
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compounds described in the literature, such as [Ir(BINAP){1,2-c-C6H10(NH2)2}(H)(Cl)]
+ and 
[Ir(COD){Ph2PhCH(Ph)CH(Me)NHMe}]
+,20, 22 complexes 2R also function quite well in aprotic 
solvents such as benzene or acetonitrile (so long as a strong base and H2 are present),
70 
demonstrating that hydrogenation, rather than transfer hydrogenation, takes place at least under 
these conditions.  
 
 
Scheme 2. Ligand and pre-catalyst object of this study.  
 
In pursuit of further mechanistic information on the catalytic action of 2R, we have tested a pre-
catalyst that internally contains the needed methoxide base as a ligand, [Ir(OMe)(COD)]2, leading 
to the conclusion that the active catalyst cannot be a neutral complex. We have also carried out 
additional experiments on non-enolizable substrates. Finally, a DFT analysis provided a 
rationalization of the experimental observations. The key result is that the hydrogenation cycle 
requires the generation of anionic species. This constitutes a new paradigm in the hydrogenation 
of carbonyl compounds, where access to an efficient outer sphere mechanism does not require the 
presence of deprotonatable ligands on the catalytic metal.    
 
Results and Discussion 
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1. Experimental studies 
1.1. Chloride vs. methoxide 
In order to probe the effect of the strong base, we have now tested a pre-catalyst that internally 
contains the needed strong base for the generation of neutral chloride-free species. As previously 
reported,70 compounds 2R (R = Et, Ph, tBu, Bz) display high activity in the hydrogenation of 
substituted acetophenones when used in iPrOH in combination with a strong base (NaOMe, KOH 
or KOtBu) under an H2 atmosphere (30 bars) at room temperature or below (e.g. see run 1 in Table 
1).  Run 2 shows that the in situ generated chloride precatalyst yields the same activity as the 
isolated complex 2Et,70 thus it is not necessary to isolate compounds 2R.  Runs 3-5 confirm the 
need of both the ligand and a strong base for activity. Hence, the methoxide analogue was also 
generated in situ from [Ir(OMe)(COD)]2 and 1Et, without attempting the isolation of putative 
[Ir(OMe)(COD)(1Et)]. Contrary to our expectations, the [Ir(OMe)(COD)]2/1Et catalyst showed 
only very small activity (run 6), comparable to that of the corresponding chlorido system (run 4) 
and no activity was recorded in the absence of ligand (run 7). However, full activity was restored 
in the presence of both the ligand and the external base (run 8). When the enantiomerically pure 
ligand was used (run 9), the enantiomeric excess of the hydrogenation product (67%) was identical 
to that observed for the reaction catalyzed by 2Et/NaOMe under the same conditions,70 suggesting 
generation of the same active species. Hence, the chlorido ligand in [IrCl(COD)]2/1Et or 2Et has no 
active role in catalysis. This conclusion matches with that of another recent study81 of the related 
RhI complexes, where complexes [Rh(COD)(1tBu)]+BF4
- and [RhCl(COD)(1tBu)] whereas shown 
to feature the same catalytic behavior. 
 
Table 1.  Results of catalytic runs for the hydrogenation of PhCOR to PhCH(R)OH.a 
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run catalyst ligand Additive R Time (h) Conv.(%) b  
1 c 2Et - NaOMe CH3 5 >99 
2 [Ir(COD)Cl]2 1Et NaOMe CH3 5 >99 
3 c 2Et - - CH3 5 0 
4 [Ir(COD)Cl]2 1Et - CH3 5 7 
5 [Ir(COD)Cl]2 - - CH3 5 0 
6 [Ir(COD)(OMe)]2 1Et - CH3 5 7 
7 [Ir(COD)(OMe)]2 - - CH3 5 0 
8 [Ir(COD)(OMe)]2 1Et NaOMe CH3 5 98 
9 [Ir(COD)(OMe)]2 1Et
 d NaOMe CH3 5 81
e 
10 [Ir(COD)Cl]2 1Et NaOMe CF3 2 42 
11 [Ir(COD)Cl]2 1Et NaOMe tBu 5 25
 
a Reaction conditions: racemic catalyst, 6.4∙10-3 mmol ; additive, 3.2∙10-2 mmol ; acetophenone, 
3.2 mmol; under 30 bars at 27°C in 2 mL of isopropanol. b Conversions determined by GC; 100% 
selectivity in (R/S)-PhCH(R)OH. c From ref. 70. d Enantiomerically pure ligand (S); e ee = 67% (S). 
 
1.2. Non enolizable substrates 
For certain hydrogenation catalysts, evidence has been advanced in favor of a mechanism 
proceeding through a metal-assisted enolization of the ketone, followed by hydrogenation of the 
enol C=C unsaturation.82, 83  Two non-enolizable ketones, PhCOR with R = CF3 and tBu, have 
therefore been used as substrates for the hydrogenation catalyzed by [IrCl(COD)]2/1Et (runs 10 
and 11, respectively). Although the catalytic activity is reduced for these systems, probably 
because of electronic effects in the former case and steric hindrance in the latter one, hydrogenation 
does take place. Hence, a hydrogenation mechanism without the need of tautomerization is 
energetically viable, at least for these two substrates.  
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1.3. Fate of the cyclooctadiene 
Additional information on the nature of the catalyst activation process was sought by treating 
the [IrCl(COD)]2/1Et mixture with H2 in the absence of substrate. This reaction results in COD 
elimination selectively as cyclooctene (observed by gas-chromatography), with no detectable trace 
of cyclooctane. Thus, hydrogenation of the COD ligand takes place at the initial stages of the 
hydrogenation catalysis and the cyclooctene product does not have sufficient binding affinity with 
the Ir center under these conditions to be further hydrogenated.  
 
2. Mechanistic considerations 
In the absence of base, activation of either [IrCl(COD)]2/1Et or [Ir(OMe)(COD)]2/1Et with H2 in 
a coordinating solvent such as iPrOH, presumably generates [Ir(H)2(1Et)(iPrOH)2]
+ after COD 
hydrogenation and cyclooctene expulsion. Related species have been observed for the rhodium 
analogue by 1H NMR using para-hydrogen induced polarization.84 Subsequent deprotonation by 
the external or internal base could lead for instance to [IrH(1Et)(iPrOH)] or to the related alkoxide 
derivative [Ir(OiPr)(1Et)(iPrOH)], from which a host of different mechanisms may be imagined. 
When the reaction is carried out in an aromatic hydrocarbon solvent, 2-arene coordination or 
alkoxide bridge formation can temporarily saturate the iridium coordination sphere, although the 
vacant position can then be saturated by the ketone substrate or by the alcohol product. This would 
well rationalize the observation of catalytic activity even in a non-coordinating solvent. However, 
this neutral system cannot be the catalytically active species, because it should be equally 
accessible also from the [Ir(OMe)(COD)]2/1Et mixture. The need of additional base to promote the 
catalytic activity points to further deprotonation with the generation of anionic species. 
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Numerous attempts have been made to identify the nature of the catalytically active species in 
solution by generation from [Ir(OMe)(COD)]2/1Et and strong base in the absence of substrate, 
under a variety of different conditions and in different solvents and notably to find supporting 
evidence for its anionic nature, using NMR spectroscopic and mass spectrometric methods. 
Because of the compounds extreme sensitivity, we have so far been unable to isolate or 
spectroscopically identify this species. Therefore, we have used computational chemistry to 
explore the likely nature and structure of a putative anionic catalyst.  
 
3. DFT computational study 
3.1. Cationic vs. neutral vs. anionic systems.  
Exploratory investigations used a simpler model of 1, henceforth abbreviated as (PS), generated 
by replacing the ferrocene linker with a –CH=CH– linker and the phenyl groups by H atoms (see 
Scheme 3), but relevant systems were subsequently calculated with the real ligand. The 
calculations included the effect of solvation by optimization in a polarizable continuum (methanol 
being used as the solvent) and the base was modelled by [MeO(MeOH)n-1]
- clusters, yielding 
[(MeOH)n],
85 with n up to 6. The proton transfer Gibbs energies are greatly dependent on n for 
small n values but then converge, remaining essentially unchanged on going from 5 to 6 (see details 
in the SI). Only the values for n = 6 will be presented. Views of all calculated structures are in the 
SI and the energy results are presented in Figure 1. Note that these computational investigations 
are only meant to assess the relative stability of various species and do not intend to suggest the 
mechanism leading from the pre-catalyst to the most stable species.   
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Scheme 3. Ligand simplification used for the initial computational investigations.  
 
Figure 1. Relative energy in methanol solution (ΔGMeOH in kcal/mol) of various species generated 
from [Ir(COD)(PS)]+/H2/[MeO(MeOH)5]
-). Only the structures of the lowest energy isomers are 
shown. See SI for the others. Color coding: green, (a isomers, H trans to P); red (b isomers, H 
trans to S); blue (numbers with no letter, primed numbers for isomers), symmetric systems.   
 
12b
-9.1
-0.4, -0.3
12a, 12a’
H2
3.2
11
12b’
-6.8
H2
0.1
13a
13b
-4.5
14’
-17.4
iPrOH
15
-7.7
iPrOH 16
-28.3
H2
14
-17.0
0.0
6a
4.0
6b 2.7
8a
-4.7
8b
H2
iPrOH
-12.3, -13.4
7b, 7b’
H2
9
-21.9
9’
-21.5
-4.8
7a
-7.5
10
-19.3
H2
iPrOH
7a’
9.3
4 4.0, 5.1
5a, 5a’
-5.2
5b
Hydrogenation
Δ
G
s
o
lv
Δ
G
s
o
lv
Δ
G
s
o
lv
H2
cationic
neutral
anionic
-1.1
5b’
 11 
Starting from the cationic [Ir(PS)(COD)]+ (3), COD removal by hydrogenation coupled to 
isopropanol coordination yields [Ir(PS)(iPrOH)2]
+ (4). This process is undoubtedly exothermic and 
the formation of cyclooctene has been experimentally demonstrated, therefore no calculations 
were carried out on this step. Complex 4 is 9.3 kcal/mol higher than the neutral system 
[Ir(OiPr)(PS)(iPrOH)] (iPrOH trans to P, isomer 6a), which is taken as the reference point on the 
G scale. H2 oxidative addition to 4 to yield [IrH2(PS)(iPrOH)2]
+ (5) can occur in 4 different ways, 
each one leading to a different stereoisomer. Indeed, H2 may add along the P-Ir-O or the S-Ir-O’ 
vector and in each case the additions either above or below the coordination plane are 
diastereotopically related because of the ligand chirality. Of the four possible isomers, 5a and 5a’ 
with a hydride ligand trans to P and 5b and 5b’ with a hydride ligand trans to S, the two latter 
ones have lower energy because the strongest trans labilizing ligand (hydride) is located trans to 
the less strongly bonded donor atom (S). Figure 1 illustrates the energy of all isomers but details 
only the geometry of the lowest energy one. All chemical drawings are provided in the SI.  
Neutral and anionic systems can be obtained by single and double deprotonation. In the neutral 
manifold, two isomers of [Ir(OiPr)(PS)(iPrOH)] (6a and 6b) are generated by deprotonation of 4, 
involving either the isopropanol ligand located trans to S (isomer 6a) or that trans to P (6b). The 
deprotonation process is energetically favorable and the lowest energy isomer is 6a where the 
isopropoxide, which is a stronger donor than isopropanol, is located trans to the weaker donor S 
atom. H2 oxidative addition to 6 to generate [IrH2(OiPr)(PS)(iPrOH)] (7) is also energetically 
favorable and may occur in four different ways, by analogy to the H2 oxidative addition to the 
protonated analogue 4 examined above. The lowest energy isomer (7b) features the strongest 
donor ligand (hydride) trans to S. These four compounds can also be generated by deprotonation 
of the corresponding isomers of 5. It now possible to envisage iPrOH reductive elimination from 
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7 to yield two isomers of [IrH(PS)(iPrOH)] (8a and 8b), which may also be generated by 
deprotonation of 5 at the metal with concomitant iPrOH release. Isomer 8b with the hydride ligand 
trans to S is the more stable one. The iPrOH reductive elimination process is endoergic by ca. 7 
kcal/mol. It is then possible to oxidatively add H2 to 8a/b to give [IrH3(PS)(iPrOH)] with three fac 
H ligands (9 and 9’, both generated from either 8a or 8b). This process is very exothermic, even 
when starting from the most stable isomer 8b (ΔG = -17.2 kcal/mol). The two products have a 
symmetric substitution pattern trans to the PS ligand, therefore only two isomers are possible, 
differing by the placement of the axial H and iPrOH ligands above and below the enantiomeric 
equatorial plane.  Putative mer isomers of 9 would be disfavored because of strong trans influence 
of the mutually trans H atoms and have not been considered. Another possible tautomer, the 7-
coordinate [IrH4(OiPr)(PS)] of formally Ir
V, converged to a nonclassical octahedral isomer of IrIII, 
[IrH2(OiPr)(H2)(PS)] (9”), at much higher energy and is not included in Figure 1. Substitution of 
iPrOH with H2 in 9 or 9’ leads to [IrH3(H2)(PS)], 10. A classical pentahydride tautomer of this 
compound (10’) was found higher in energy (see SI). Hence, the lowest energy species in the 
neutral manifold is the trihydride complex 9. This will be considered as the putative catalyst resting 
state in hydrogenation cycles carried out in the absence of base (vide infra).  
Concerning the anionic species, [Ir(OiPr)2(PS)]
- (11) is obtained by deprotonation of 6a or 6b, 
[IrH2(OiPr)2(PS)]
- (12, four isomers) by H2 oxidative addition to 11 or by deprotonation of 7, 
[IrH(OiPr)(PS)]- (13, two isomers) by iPrOH reductive elimination from 12 or by deprotonation 
of 8, [IrH3(OiPr)(PS)]
- (14, two isomers) by H2 oxidative addition to 13 or by deprotonation of 9, 
[IrH2(PS)]
- (15) by iPrOH reductive elimination from 14, and finally [IrH4(PS)]
- (16) by H2 
oxidative addition to 15 or by deprotonation of 10. Wherever there are isomeric possibilities, as 
noted above for the cationic and for the neutral systems, the most stable isomer is always the one 
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placing the stronger σ donor ligand trans to S and the weaker one trans to P. Also parallel to the 
trends already noted for the cationic and neutral manifolds, the H2 oxidative addition processes are 
exoergic and the iPrOH reductive elimination processes are endoergic, though by a lesser amount. 
This phenomenon yields a trend of decreasing energy upon substitution of OiPr ligands with 
hydrides by the H2 oxidative addition - iPrOH reductive elimination sequence. 
The most important energetic result, however, concerns the deprotonation. While for certain 
stoichiometries the most stable system is the neutral one (e.g.  6a vs. 4 and 11; 7b vs. 5b and 12b; 
9 vs. 14) and the deprotonation of 8b to 13b is nearly thermoneutral, the tetrahydrido system 16 is 
much more stabilized than the protonated neutral version 10 and is by far the most stabilized 
species overall. It is therefore likely to correspond to the catalyst resting state. Note that 16 is 
isoelectronic with the [IrH4(PR3)2]
- (R = iPr, Ph) anions,86, 87 which were isolated and fully 
characterized as salts of crown-ether-stabilized alkali metals.86, 88  
After obtaining preliminary indications of the likely identity of the most stable solution species 
from the above exploratory investigations, selected calculations were carried out on the full system 
in order to assess the importance of electronic and steric effects associated to the ligand 
simplification. The calculations were carried out using 1Ph as ligand at the full quantum mechanical 
level. The relative energies for all systems investigated did not greatly vary relative to those of the 
simpler model: cationic 5bPh is at -1.5 kcal/mol relative to 6aPh (vs. -5.2 kcal/mol for the model 
system), neutral 7bPh, 9Ph and 10Ph are respectively at -11.9, -20.4 and -18.0 kcal/mol (vs. -13.5, -
21.9 and -19.3 kcal/mol for the model system) and anionic 12Ph, 14’Ph and 16Ph are respectively at 
-7.8, -16.2 and -25.8 kcal/mol (vs. -9.1, -17.4 and -28.3 for the model system) showing a limited 
effect of the ligand backbone and substituents. The deprotonation from 10Ph to 16Ph is exoergic by 
-7.8 kcal/mol (cf. -9.0 kcal/mol for the model system). The geometry of 16Ph, the lowest energy 
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system calculated by this study, is depicted in Figure 2. To conclude, the DFT calculations suggests 
a thermodynamically favorable transformation of the iridium precatalysts 2R to the octahedral 
anionic tetrahydride complex 16R in the presence of H2 and a strong base in alcohol solvents.  
 
Figure 2. View of the optimized geometry for the anionic complex [IrH4(1Ph)]
- (16Ph).  
3.2. Relevance of anionic hydrides in hydrogenation catalysis.  
Quite some time ago, Pez et al. proposed the role of anionic hydride species in the catalytic 
hydrogenation of several oxygenated substrates, following the isolation and characterization of 
ortho-metallated [K(Ln)][RuH2(κ2:C,P-o-C6H4PPh2)(PPh3)2] salts (Ln = solvent or crown ether).89-
92 However, detailed investigations by Halpern et al. subsequently demonstrated that the Pez 
complex, which yields [RuH3(PPh3)3]
- under H2,
93, 94 is reversibly protonated to [RuH2(H2)(PPh3)3] 
in alcohol solvents and that the latter “tetrahydride” complex is the real catalyst.95 It seems that, 
after these debated contributions, the catalytic activity of anionic hydride complexes has no longer 
been considered.  
Ir
H
H
H
H
P
S
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This Pez/Halpern contribution on the protonation state of the ruthenium-phosphine-hydride 
catalyst gives us the opportunity to benchmark our computational system. We have therefore 
computed the [RuH3(PPh3)3]
-/[RuH2(H2)(PPh3)3] system using the same base and solvent models 
and level of theory as for the above iridium study. Three isomeric structures were optimized for 
the neutral system, one non-classical ruthenium(II) complex with a dihydrogen ligand, 
[RuH2(H2)(PPh3)3], and two classical ruthenium(IV) tetrahydride complexes (see Figure 3). The 
lowest energy isomer is the non-classical one, in agreement with NMR evidence96, 97 and with the 
solid state structure of a related complex.98 The next lowest isomer has a 1:3:3 (capped octahedron) 
geometry, an H atom capping the fac (PPh3)3 face (3.2 kcal/mol higher than the nonclassical 
minimum).  The less stable geometry can be described as a pentagonal bipyramid with two axial 
and one equatorial PPh3 ligands (4.3 kcal/mol higher than the minimum). The anionic trihydride 
complex [RuH3(PPh3)3]
- has a regular octahedral geometry with a fac arrangement of the hydrides 
and PPh3 ligands, as in the experimentally determined structures of [K(18-crown-
6)][RuH3(PPh3)3]
99 and [Li(THF)3][RuH3(PPh3)3].
100   
Using the same base and conjugate acid models also employed to calculate the deprotonation 
energetics of the iridium system, namely the [MeO(MeOH)5]
- and (MeOH)6 clusters, the 
deprotonation of the tetrahydride complex was found nearly thermoneutral (-0.7 kcal/mol). This 
result is in good agreement with the experimental evidence of an equilibrated process for the 
[RuH3(PPh3)3]
-/[RuH2(H2)(PPh3)3] system (the experimental study used cyclohexanol in THF-
D8)
95 and confirms that the Ir system has greater tendency to be anionic in basic alcohol relative 
to the Pez/Halpern Ru system.  
 16 
 
Figure 3. Relative energy in methanol solution (ΔGMeOH in kcal/mol) of three “RuH4(PPh3)3” 
isomers and of the deprotonated complex [RuH3(PPh3)3]
-.  
 
3.3. Exploration of the hydrogenation mechanism from the anionic complex 16.  
The hydrogenation of polar substrates may in principle occur by several different mechanisms. 
The most common ones are the inner-sphere, or coordination/insertion mechanism, which can be 
further classified into monohydride and dihydride mechanisms depending on the number of 
available hydrides on the catalytic metal and on the order of the insertion/H2 activation/reductive 
elimination events, and an outer-sphere mechanism where the catalyst provides a hydride and a 
proton to the substrate without the need of substrate coordination, either concertedly (e.g. as in 
Scheme 1) or stepwise. The fundamental problem of system 16 is that neither a coordination site 
for a ketone coordination/insertion pathway nor a transferrable proton for the outer sphere pathway 
are available. A possible pathway, however, follows that recently presented by Dub et al. to 
reappraise the hydrogenation mechanism in the presence of Noyori’s catalyst,68 concluding that 
(0.0)
(-0.7)
(3.2)
(4.3)
[RuH4(PPh3)3]
[Ru(H2)H2(PPh3)3]
[RuH3(PPh3)3]
-
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the base (tBuOK) serves to deprotonate the amine in [RuH2(BINAP)(NH2CHPhCHPhNH2)]. The 
operating cycle occurs on a [K]+[RuH2(BINAP)(NHCHPhCHPhNH2)]
- system with stepwise 
hydride transfer, H2 coordination and proton transfer, whereas II (Scheme 1) is only an off-loop 
species. 
Exploratory calculations (see Figure 4) where initially run on the simpler model and then 
repeated for the best cycle on the full system. Only the energies related to the full system are 
presented in Figure 4; once again, they do not substantially differ from those of the simpler model 
(see SI for the details). In addition, single-point calculations on all fixed optimized geometries 
were also repeated with a larger basis set (BS2, see Computational Details). The calculations used 
acetone as model substrate, methanol as model solvent and Na(MeOH)n
+ (n = 3) as counterion, 
while using cation models with n > 3 yielded higher G values for all systems. The cycle starts with 
a [Na+(MeOH)3∙∙∙16Ph] ion pair (17Ph). The Na+ cation anchors the ketone substrate in the first step 
(17Ph-18Ph). A very recent paper has also highlighted the role of the alkali metal cation, modeled 
as [Na(H2O)6]
+, in the formate decarboxylation catalyzed by an iron pincer complex.101  The 
acetone adduct 18Ph is only slightly more stable, by 0.4 kcal/mol, than the precursor 17Ph, but 
becomes less stable after recalculation with BS2.  Hydride transfer follows to generate a Na+-
anchored alkoxide (19Ph) held in the Ir coordination sphere by σ C-H coordination, which then 
rearranges to a more stable µ2-O isomer (20Ph). In the next step, H2 displaces OiPr from the Ir 
coordination sphere to yield 22Ph through a van der Waals adduct (21Ph) as a local minimum. The 
H2 ligand in 22Ph then delivers a proton to the Na
+-bonded OiPr ligand to yield an isopropanol 
adduct 23Ph and the cycle is completed by product expulsion. The resting state is the acetone adduct 
18Ph (or the tetrahydrido complex 17Ph at the BS2 level) and the rate determining transition state, 
TS(21-22)Ph, corresponds to the isopropoxide substitution by H2. Therefore, the hydrogenation is 
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in essence an outer sphere process with stepwise H-/H+ transfer to the sodium-activated ketone, 
but the proton is not initially present on the catalyst; it is only provided in a later step after H2 
activation. The cycle energy span is 18.2 kcal/mol (or 17.3 kcal/mol at the BS2 level), in good 
agreement with the observed high TOF at room temperature.70 Indeed, for a TON of 500 in 2 h at 
298K, a span of 19.0 kcal/mol can be calculated using the Eyring equation, but the initial TOF is 
greater for an estimated span closer to the computed value. Note that the alkali metal cation plays 
a crucial role in this mechanism, insuring the ketone activation in intermediate 18. Evidence in 
favor of an active role played by the alkali cation has been documented for RuII-diamine-based 
hydrogenation catalyst.102, 103  
 
 
Figure 4. Computed cycle for acetone hydrogenation catalyzed by [Na(MeOH)3][IrH4(1Ph)] (17Ph). 
For each species the Gibbs energies (optimized geometry with BS1/fixed geometry with BS2) in 
kcal/mol are given in parentheses below the compound symbol.    
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It is of interest to compare the energy profile of this cycle with that recently presented by Dub 
et al. for the related [K]+[RuH2(BINAP)(NHCHPhCHPhNH2)]
- species.68 For the deprotonated 
Noyori catalyst, where a naked K+ cation was used as opposed to our more realistic MeOH-
solvated Na+ cation, the calculated rate-determining transition state was the ketone insertion step. 
This step yields an intermediate where the alkoxide ligand is not coordinated to the alkali metal 
but rather forms a hydrogen bond with the N-H group and a very weak σ C-H coordination to the 
Ru center. In this way, there is no need to displace a strongly bonded anionic ligand to coordinate 
H2, as opposed to our calculated cycle in which the alkoxide rearranges to bridge the Ir and Na 
metals. 
3.4. Exploration of the hydrogenation mechanism from the neutral complex 9.  
The next question to be addressed is why catalysis is not efficient in the absence of a strong base. 
This means that the best available cycle from a neutral iridium complex must have a higher energy 
span than the anionic system presented above. The lowest energy species calculated within the 
neutral manifold (which is accessed from [Ir(OMe)(COD)]2/1Et when no strong base is added) is 
the trihydride complex 9. Therefore, this species is likely the resting state of any putative operating 
cycle under base-free conditions. Species 9 has an easily accessible vacant position for a 
coordination/insertion mechanism, made available by isopropanol dissociation, and also a proton 
(on the coordinated alcohol) for an outer sphere pathway.  
Here, again, initial explorations were run on the simpler model system. Figure 5 shows the best 
cycle, while full details are provided in the SI. The first step is dissociative replacement of the 
isopropanol ligand to yield the acetone complex 25 via the coordinatively unsaturated trihydride 
complex 24. Isopropanol dissociation has a very small energy cost (3.8 kcal/mol) because of the 
strong trans labilizing effect of the hydride ligand. The next step is hydride insertion to yield the 
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alkoxide complex 26, of which two isomers are possible (26a with the alkoxide trans to S, 
represented in Figure 5, and 26b with the alkoxide trans to P). Isomer 26b is actually lower in 
energy (at 3.8 kcal/mol relative to 9) because the two strongest trans labilizing ligands (the hydride 
and the P donor) are not mutually trans. However, isomer 26a leads to the lowest span cycle. Note 
that the isopropoxide ligand in 26a occupies the same equatorial position previously occupied by 
the hydride ligand: the axial ketone moves toward the equatorial plane concertedly with the 
insertion process. Therefore, this is an example of a real insertion, as opposed to a migratory 
insertion which characterizes the alkyl migration toward carbonyl groups in carbonylation 
processes or toward coordinated olefins in coordination polymerization processes. The catalytic 
cycle is then closed by H2 coordination yielding the adduct 27a’ and heterolytic activation, to 
transfer a proton to the coordinated isopropoxide and regenerate the hydride ligand via the rate-
determining transition state TS(27a’-9). This pathway involves coordination of H2 to the equatorial 
position with concomitant rearrangement of the isopropoxide ligand, which migrates toward the 
axial position. The alternative H2 coordination to the vacant axial site trans to the hydride ligand 
in 26a, while yielding a lower energy dihydrogen complex 27a, leads to a higher energy TS for 
the final heterolytic activation step. It is also possible to envisage an alternative outer sphere 
pathway for the concerted transfer of a proton from the coordinated isopropanol and a hydride 
ligand from 9 to the outer sphere acetone (indicated as the dashed pathway in Figure 5). This, 
however, would generate the same dihydro-isopropoxide complex 26. The coordination/insertion 
pathway that has already been found for this transformation is not the cycle rate-determining 
process. Therefore, even if the outer sphere H+/H- transfer were competitive with the 
coordination/insertion pathway, the cycle would remain limited by the rate of H2 activation and 
catalyst regeneration and the cycle energy span would not change. 
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Figure 5. Best cycle for acetone hydrogenation catalyzed by [IrH4(1Ph)(iPrOH)] (9). For each 
species the Gibbs energy in kcal/mol is given in parentheses below the compound symbol.    
 
The catalyst regeneration step from 26 to 9 can also be envisaged in another way, by inverting 
the H2 addition and iPrOH formation steps. Isopropoxide-hydride coupling could take place first, 
to generate the [IrH(PS)(iPrOH)] system (8), followed by H2 oxidative addition. Thus, the 
mechanism would operationally become a “dihydride coordination/insertion” mechanism, as 
opposed to that shown in Figure 5 which is operationally a “monohydride coordination/insertion” 
mechanism. This possibility has also been explored on the model system, as shown in Figure 6. In 
this case, the best pathway involves the lower energy isomer 26b.  A direct transfer of the axial H 
atom from Ir to the isopropoxide ligand requires a very high activation barrier, but the involvement 
of an additional solvent molecule, modelled with methanol, makes the process easier through a 
proton shuttle mechanism. 26b forms an H-bonded adduct with MeOH, 26b∙MeOH, which leads 
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to 8b∙MeOH via TS(26b-8b)∙MeOH. While this TS is at lower energy relative to the non-MeOH 
assisted mechanism, it still remains at higher energy than the alternative rate-determining TS for 
the monohydride mechanism in Figure 5. Once arrived at the IrI hydride complex 8b, the cycle is 
completed by H2 oxidative addition. The TS of this final step was not calculated since the high 
energy of TS(26b-8b)∙MeOH already makes this pathway less viable than the monohydride 
coordination/insertion mechanism of Figure 5.  
 
 
 Figure 6. Alternative O-H coupling/H2 oxidative addition pathway for the regeneration of the 
resting state 9 from 26b.    
 
Following this preliminary exploration and given the general fidelity of the relative energies 
found for the real system to those of the simpler model (vide supra), the cycle energy span for the 
real system was assessed by calculating only the resting state 9Ph, the key intermediate 27a’Ph for 
26b
(3.8) (2.7)
(14.0)
(25.0)
(-5.8)
9
8b∙MeOH
TS(26b-8b)∙MeOH
(11.4)
8b
26b∙MeOH
(32.9)
TS(26b-8b)
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the best cycle (found at 19.6 kcal/mol from 9Ph), and the rate determining transition state TS(27a’-
9)Ph, which was found at 26.3 kcal/mol from 9Ph.  The energy span of this cycle is therefore 26.3 
kcal/mol, i.e. 8.1 kcal/mol higher than that afforded by the anionic hydride 17Ph. This result agrees 
with the experimental evidence that hydrogenation is efficient only when a strong base in present. 
The rate determining transition state for the neutral cycle is unfavorable because it involves 
heterolytic H2 activation in a structure with two mutually trans strong ligands (H and OiPr), 
whereas in the anionic cycle of Figure 4 the trans influence of these two ligands is alleviated by 
the alkoxide coordination to sodium and by the incipient substitution with H2. 
 
Conclusion 
 
We have experimentally demonstrated that the Ir ketone hydrogenation catalyst generated by 
activation of 2 cannot be a neutral iridium complex; the need of additional strong base suggests 
the generation of an anionic active complex. Calculations with the inclusion of implicit and explicit 
solvation effects and of the Na(MeOH)3
+ counterion suggest that the contact ion pair 
[Na+(MeOH)3∙∙∙Ir-H4(PS)], containing an anionic tetrahydride complex similar to already 
described bis(phosphine) systems, is the catalyst resting state and yield a cycle with an energy span 
consistent with the observed catalytic activity. The base has the dual role of generating the anionic 
complex and providing the Lewis acid co-catalyst for ketone activation. The cycle is similar to that 
recently presented by Dub et al. for the Noyori catalyst.68 However, we have demonstrated here 
for the first time that an outer sphere mechanism for ketone hydrogenation can be accessed also in 
the presence of “non-deprotonatable” supporting ligands, with the strong base playing a crucial 
role in the generation of anionic species through a sequence of H2 addition and deprotonation steps. 
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Current work aims at studying the catalyst resting state by experimental methods. The role of the 
cation in the ketone activation will also be investigated in further combined experimental and 
computational work. 
 
Experimental Section 
 
All operations were carried out under an atmosphere of argon under standard glove-box and 
Schlenk-line techniques. Isopropanol was purified by distillation over CaH2. Ligand 1Et and 
complex 2Et were prepared as previously described.69, 104 Compounds [Ir(OMe)(COD)]2 (Strem), 
acetophenone (Aldrich, 99%), 2,2,2-trifluoroacetophenone (Lancaster, 98%) and phenyl tert-butyl 
ketone (Alfa Aesar, 98%) were used as received.   
 
General procedure for asymmetric hydrogenation.  In a glove box, a solution of 6.4·10-3 
mmol of catalyst (6.4·10-3 mmol of 2Et or 6.4·10-3 mmol of 1Et and 6.4·10-3 mmol of metallic 
precursor), 3.2·10-2 mmol of NaOMe (5 equiv, if appropriate) and 0.37 mL of acetophenone (381 
mg, 3.2 mmol, 500 equiv) in 2 mL of iPrOH was transferred into a 5 mL glass ampoule which was 
then placed into a stainless steel autoclave. The reaction vessel was pressurized to the required H2 
pressure (30 bars) and stirred with a magnetic bar for the desired time at 27 °C). The reaction was 
stopped by release of pressure and quenching of the solution with CH2Cl2 at room temperature. 
The crude materials were obtained by evaporation of the solvent on rotavapor. The product was 
finally analysed by chiral GC (Supelco BETA DEX 225). 
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Computational Details. The calculations were carried out within the DFT approach with the 
M06 functional,105 including an ultrafine integration grid, as implemented in Gaussian 09.106  All 
geometry optimizations were carried out using a basis set BS1, which consisted of the SDD basis 
set and ECP for the Ir and Fe atoms,107 augmented with f polarization functions (α = 0.938 and 
2.462, respectively),108 the 6-31G(d) basis set for all other heavy atoms, and the 6-31G(d,p) basis 
set for all H atoms.109 All molecules involved in the best catalytic cycle (see Results and 
Discussion) were also recalculated at their fixed geometries with a more extended basis set BS2 
(same SDD functions for Ir and Fe, plus the 6-311++G(d,p) functions for all other atoms). The 
effect of the solvent was included by the SMD polarizable continuum110 in methanol (ε=35.688) 
during the geometry optimizations with BS1 and single point calculations with BS2. All of the 
energies presented in the text are Gibbs energies in methanol (ΔGMeOH). A correction of 1.95 
kcal/mol was applied to all G values to change the standard state from the gas phase (1 atm) to 
solution (1 M).111  
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Synopsis 
Activation of [IrCl(COD)(PS)], [IrCl(COD)]2/PS or [Ir(OMe)(COD)]2/PS (PS = ferrocenyl 
phosphine thioether) under H2 requires the presence of a strong base such as MeONa in order to 
yield an efficient ketone hydrogenation catalyst. A computational investigation using 
[MeO(MeOH)n]
- as a model base for deprotonation yields anionic [IrH4(PS)]
- as the lowest energy 
species. A catalytic cycle starting from the [Na+(MeOH)3∙∙∙Ir-H4(PS)] contact ion pair yields an 
energy span in agreement with the experimentally observed efficiency. 
 
